| 题名 | Maximum androgen blockade using LHRH agonist buserelin in combination with short-term (two weeks) or long-term (continuous) cyproterone acetate is not superior to standard androgen deprivation in the treatment of advanced prostate cancer. Final analysis of EORTC GU Group Trial 30843. European Organization for Research and Treatment of Cancer (EROTC) Genito-Urinary Tract Cancer Cooperative Group |
| 作者 | de Voogt HJ, Studer U, Schröder FH, Klijn JG, de Pauw M, Sylvester R |
| 链接 | http://www.ncbi.nlm.nih.gov/pubmed/9519356 |
| 欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |